Rising Adoption of Mobile-based Respiratory Disease Testing Applications anticipated to open up new avenue for Respiratory Disease Testing Market
![]() |
Respiratory Disease Testing Market |
Respiratory
disease testing market involves testing for various respiratory diseases such
as asthma, chronic obstructive pulmonary disease (COPD), lung cancer,
pneumonia, tuberculosis, and sleep apnea. The common types of respiratory
disease testing include laboratory tests, imaging tests, and pulmonary function
tests. Laboratory tests include complete blood count, arterial blood gas,
sputum culture etc. Imaging tests comprise chest X-ray, CT scan, MRI etc.
Pulmonary function tests are performed to measure lung function parameters like
lung volumes, diffusion capacity and airflow limitation.
The
global Respiratory Disease Testing Market is estimated to be valued at US$
3,232 Mn in 2023 and is expected to exhibit a CAGR of 4.0% over the forecast period 2023 to 2030, as highlighted
in a new report published by Coherent Market Insights.
Market Dynamics:
Increased adoption of mobile-based respiratory disease testing applications is
anticipated to drive the market growth during the forecast period. Mobile based
applications provide an easy way to monitor lung functions at home. For
instance, companies like Vitalograph offer mobile compatible spirometers and
lung function testing apps. Increased research activities focusing on
development of advanced diagnostic tests is another major factor boosting the
market growth. Growing geriatric population worldwide which is more prone to
respiratory diseases is fueling the demand for respiratory disease testing.
Furthermore, rising prevalence of smoking and air pollution are leading to
increased incidence of respiratory diseases thereby propelling the market
growth.
Here is the 700 words content for the given market name:
Segment Analysis
The respiratory disease testing market can be segmented based on tests,
diseases, end-users and regions. Based on test types, pulmonary function tests
are dominating the market as it is considered highly effective for tests
related to lung capacity and airway disease diagnosis. Pulmonary function tests
measure how much air a person can inhale and exhale with time and helps
understand the functioning of lungs better.
PEST Analysis
Political: Governments across countries are raising awareness about respiratory
diseases through campaigns and allocating higher healthcare budgets which is
positively impacting the market growth.
Economic: Rise in per capita healthcare expenditure is enabling more people to
opt for respiratory disease diagnosis tests. Growing middle class population
with increased disposable incomes is also supporting market growth.
Social: Growing pollution levels and changing lifestyle factors resulting into
increased smoking is leading to higher prevalence of respiratory diseases. This
is increasing the demand for associated tests in the market.
Technological: Developments in medical imaging technologies like CT scans and
introduction of portable diagnostic devices are enabling easy and affordable
respiratory disease diagnosis. This is positively influencing the market.
Key Takeaways
The global Respiratory
Disease Testing Market Share is expected to witness high growth, exhibiting
CAGR of 4.0% over the forecast period, due to increasing pollution levels
globally.
The Asia Pacific region is projected to witness fastest growth in the
respiratory disease testing market due to rising health awareness, growing
geriatric population and escalating pollution in counties like China and India.
Regionally, North America dominated the market and is expected to continue its
dominance during the forecast period attributed to growing prevalence of
respiratory diseases like asthma and presence of major players in the region.
Key players operating in the respiratory disease testing market are CareFusion
Corporation, Carestream Health, Inc., COSMED, Futuremed America, Inc., GE
Healthcare, MGC Diagnostics Corporation, ndd Medical Technologies, Inc., Nihon
Kohden Corporation, Perkin Elmer, Inc., FUJIFILM Healthcare Corporation,
Philips Healthcare,Roche Healthcare, Beckton Dickinson and Company, Koninklijke
Philips N.V. , ResMed Inc., Medtronic, Abbott Diagnostics, and Quest
Diagnostics.
Key players like Philips Healthcare are focusing on strengthening their market
position through new product launches. For instance, in 2019, Philips
Healthcare launched new digital diagnostic solutions for respiratory
conditions.
For
more insights, Read-
https://www.pressreleasebulletin.com/respiratory-disease-testing-market-trends-share-analysis/
Comments
Post a Comment